🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 VegCap(s) Serving Size
100 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Devil's Claw
525 mg

Other Ingredients

Cellulose Rice Bran Extract Blend

Label Claims — Verification

All Other
Structure/Function

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Dairy Free

Product Information

📋 Directions for Use

Directions: Use only as directed. Take 1 VegCap three times daily with a meal or glass of water.

⚠️ Warnings & Precautions

Warning: Do not use if safety seal if broken or missing.

Keep out of reach of children.

Keep your licensed health care practitioner informed when using this product.

California Residents Only Warning: Reproductive Harm - www.P65Warnings.ca.gov.

🧪 Formulation Notes

True herbs

Joint health

Vegan

Discussion: Native to southwest Africa, devil's claw grows naturally in the Kalahari desert and steppes of Namibia. Devil's claw derives its name from the unique appearance of its large claw-line hooked fruit. Devil's claw may provide nutritive support for joint health and overall body comfort.

Additional Information

Lab Verified Vegan

Since 1973, we've scoured the globe for the highest quality ingredients, connecting you with the most efficacious supplements that help you live brighter & embrace the moments that matter most.

Store in a cool, dry place.

100% PCR Bottles

Product Details

UPC / SKU 0 76280 01220 0
DSLD Entry Date 2025-03-25
Product Type Botanical
Form Capsule
Brand Solaray
DSLD ID 325966
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.